Related Articles
Significance of combined TGF‑β1 and survivin expression on the prognosis of patients with triple‑negative breast cancer
Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer
Association between transforming growth factor-β1 expression and the clinical features of triple negative breast cancer
Transforming growth factor‑β, insulin‑like growth factor I/insulin‑like growth factor I receptor and vascular endothelial growth factor‑A: Prognostic and predictive markers in triple‑negative and non‑triple‑negative breast cancer
Cyclooxygenase‑2 expression in non‑metastatic triple‑negative breast cancer patients